Roberto Mateo - Gilead Sciences Inc | 人才画像

基本信息

浏览量：3

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 27 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Oral Dosing of the Nucleoside Analog Obeldesivir is Efficacious Against RSV Infection in African Green Monkeys

Jared Pitts, J. Lizbeth Reyes Zamora,Savrina Manhas,Thomas Aeschbacher, Josolyn Chan, Vincent Cutillas, Varsha Nair, Nicolas C. Riola,Arya Vijjapurapu,Meghan S. Vermillion,Stacey Eng,Christopher Richards,Dong Han,Jason K. Perry,Subhra Chaudhuri, Iris Liu,Clarissa Martinez,Nadine Peinovich,Kai-Hui Sun, Arthur Cai,Ross Martin,Jasmine Moshiri,Charlotte Hedskog,Darius Babusis,Dustin S. Siegel,Rao Kalla,Vasanthi Avadhanula,Pedro A. Piedra,Kim Stobbelaar,Peter L. Delputte,Caleb Marceau,Roberto Mateo,Jenny Svarovskaia,Hongmei Mo,Raju Subramanian,Richard L. Mackman,Tomas Cihlar,Simon P. Fletcher,John P. Bilello

biorxiv（2025）

引用0浏览0引用

Five-year Treatment with Tenofovir Alafenamide Achieves High Rates of Viral Suppression, Alanine Aminotransferase Normalization, and Favorable Bone and Renal Safety in Chinese Chronic Hepatitis B Patients

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2024)

引用0浏览0WOS引用

No Amino Acid Substitution in HBV PreS1, HDAg, or NTCP Associated with Suboptimal Response to Bulevirtide in Combination with Pegylated Interferon Alfa-2A Treatment in Participants with Chronic Hepatitis Delta: Results from MYR204 a Phase 2b Study

JOURNAL OF HEPATOLOGY (2024): S737-S738

引用0浏览0引用

SAT-405 Differential Expression and Sequence Variants of Sodium Taurocholate Cotransporting Polypeptide (NTCP) Do Not Affect HDV Inhibition by Bulevirtide (BLV)

Simin Xu,Thomas Aeschbacher,Savrina Manhas, Chunfeng Li,Ross Martin,Yang Liu,Evguenia Maiorova,Hongmei Mo,Roberto Mateo

Journal of Hepatology (2024): S750

引用0浏览0引用

Eight-year Efficacy and Safety of Tenofovir Alafenamide for Treatment of Chronic Hepatitis B Virus Infection: Final Results from Two Randomised Phase 3 Trials

ALIMENTARY PHARMACOLOGY & THERAPEUTICSno. 11-12 (2024): 1573-1586

引用0浏览0WOS引用

IDDF2024-ABS-0195 Long-term Efficacy of Tenofovir Alafenamide in HBeAg-positive and -Negative Chronic Hepatitis B Patients Treated for Up to 8 Years in 2 Phase 3 Studies

Wai Kay Seto,Maria Buti,Kosh Agarwal,Henry Lik Yuen Chan,Young-Suk Lim, Maurizia Brunetto,Wan-Long Chuang, Harry Janssen,Scott Fung,Namiki Izumi, Maciej Jablkow,Frida Abramov, Hongyuan Wang,Leland Yee,Roberto Mateo,John Flaherty, Calvin Pan,Dr Shalimar,Patrick Marcellin,Edward Gane

Clinical Hepatology (2024)

引用0浏览0引用

IDDF2024-ABS-0208 No Resistance to Tenofovir Alafenamide (TAF) in Adult, HBeAg-positive and HBeAg-negative Participants with Chronic Hepatitis B Infection Treated with TAF for Up to 8 Years

Henry Chan,Patrick Marcellin, Calvin Pan,Roberto Mateo,Tahmineh Yazdi,Silvia Chang,Dong Han,Lindsey May,Caleb Marceau,Christopher Richards,Savrina Manhas, Pui Yan Ho, Robert Li,Simin Xu,Clarissa Martinez, Yang Liu,Nadine Peinovich, Andrew Lopez,Frida Abramov,John Flaherty,Hongmei Mo,Dr Shalimar,Namiki Izumi,Young-Suk Lim,Maria Buti

Clinical Hepatology (2024)

引用0浏览0引用

KINETICS OF HEPATITIS B SURFACE ANTIGEN LOSS FOLLOWING 8 YEARS OF TENOFOVIR-BASED TREATMENT IN HEPATITIS B E ANTIGEN-NEGATIVE AND HEPATITIS B E ANTIGEN-POSITIVE PATIENTS WITH CHRONIC HEPATITIS B

Jeong Heo,Scott Fung,Maria Buti,Roberto Mateo,Tahmineh Yazdi,Frida Abramov,John Flaherty,Thomas Aeschbacher, Yu Hu,Silvia Chang,Hongyuan Wang,Hongmei Mo,Young-Suk Lim,Edward Gane,Kosh Agarwal

HEPATOLOGY (2024): S624-S625

引用0浏览0引用

A PHASE 1B, OPEN- LABEL STUDY TO EVALUATE THE SAFETY AND EFFICACY OF NOVEL HEPATITIS B VIRUS COMBINATION THERAPIES IN PATIENTS LIVING WITH CHRONIC HEPATITIS B

Edward Gane,Tien Huey Lim,Jing Hieng Ngu, Dana Tedesco, Ran Duan,David Pan, Irina Botros, Naveed Shaik,Roberto Mateo,Scott Balsitis,Jeffrey Wallin,Frida Abramov,Audrey Lau,Grace Wong

HEPATOLOGY (2024): S258-S259

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn